Patient Guide: An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 153 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05494606
Status: ACTIVE_NOT_RECRUITING
Condition: Ulcerative Colitis
Phase: Research Study

Where You Can Participate

This study is available at 153 locations across the country.

Top locations include:
  • • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires
  • • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires
  • • Cordoba,
  • • And 150 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice - Join Clinical Trial NCTNCT05494606

How to Join This Clinical Trial - NCTNCT05494606

Learn how to participate in this clinical trial studying an investigational therapy for Ulcerative Colitis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Ulcerative Colitis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Ulcerative Colitis
Treatment Being Tested
Investigational treatment
Study Phase
Clinical trial phase - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05494606 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 153 locations. Find a study site near you:

Clinical Research Site

Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires 1115 - Argentina

Status: Contact for availability

Clinical Research Site

Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires 1280 - Argentina

Status: Contact for availability

Clinical Research Site

Cordoba, 5016 - Argentina

Status: Contact for availability

Clinical Research Site

Blacktown, New South Wales 2148 - Australia

Status: Contact for availability

Clinical Research Site

Kingswood, New South Wales 2747 - Australia

Status: Contact for availability

Clinical Research Site

North Mackay, Queensland 4740 - Australia

Status: Contact for availability

Clinical Research Site

Heidelberg, Victoria 3084 - Australia

Status: Contact for availability

Clinical Research Site

Parkville, Victoria 3050 - Australia

Status: Contact for availability

Clinical Research Site

Calgary, Alberta T2N 4Z6 - Canada

Status: Contact for availability

Clinical Research Site

Edmonton, Alberta T5R 1W2 - Canada

Status: Contact for availability

And 143 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this clinical trial for Ulcerative Colitis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships